Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance

Go back to Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance

Leerink Partners Remains Sidelined on Medivation (MDVN) Following an EPS Beat

February 26, 2016 7:15 AM EST

Leerink Partners maintained a Market Perform rating on Medivation (NASDAQ: MDVN), and cut the price target to $39.00 (from $41.00), following the company's 4Q earnings report. Non GAAP EPS was $0.29, ahead of consensus estimates of $0.25. As expected R&D surged to fund the companys recently... More

Medivation (MDVN) Tops Q4 EPS by 5c, Offers Guidance

February 25, 2016 4:38 PM EST

Medivation (NASDAQ: MDVN) reported Q4 EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at $377.75 million versus the consensus estimate of $371.94 million.

GUIDANCE:

Medivation sees FY2016 EPS of $1.30-$1.40, versus the consensus of... More